Questions with the most recent answer or edit.
Setup, so nobody has to ask: orforglipron · fourteen days. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
Numbers first: an 18G drawing needle · orforglipron · 2 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather…
Details up front: cagrilintide · 2–8 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
For reference: Changsha · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: fatigue · ecnoglutide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Concretely: 30 units · 5 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake here that…
The particulars: potassium · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Concretely: TFC · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
For reference: fatigue · 1,000 kcal. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…
What I have: Tianjin · the United Kingdom. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I am working with: lot-specific certificate · KP. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
The case in front of me: ecnoglutide · 20 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
For reference: dizziness · semaglutide · STEP 5. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that…
Setup, so nobody has to ask: nausea · four · semaglutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
The case in front of me: TFC · liraglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
Setup, so nobody has to ask: dulaglutide · three days. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
I would rather spend on verification than on volume. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
The specifics, since they change the answer: cystatin C · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather…
Details up front: 8 mg · sixteen weeks · injection-site erythema. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I…
The specifics, since they change the answer: oral semaglutide · SURPASS-3. I have the document in front of me and I can read the numbers. What I cannot do is…
For reference: 10 units · 2.5 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
Numbers first: mazdutide · six weeks · minus 80 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to…
Numbers first: eGFR · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…